LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 P&L / Income Statement

LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

70,382,000 US dollars

Cost of sales

19,618,000 US dollars

Gross profit

50,764,000 US dollars

Total operating expenses

30,365,000 US dollars

Income from operations

20,399,000 US dollars

Other income (expense), net (calculated)

1,790,000 US dollars

Income before income taxes

22,189,000 US dollars

Provision for income taxes

5,139,000 US dollars

Net income

17,050,000 US dollars

UNITED STATES

38,250,000 US dollars

GERMANY

5,341,000 US dollars

CANADA

4,551,000 US dollars

UNITED KINGDOM

3,725,000 US dollars

Other countries

18,515,000 US dollars

General and administrative

11,110,000 US dollars

Research and development

4,847,000 US dollars

Sales and marketing

14,408,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.